Calidi Biotherapeutics, Inc. (CLDI)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Aug. 19, 2025 | CORRESP | Neutral/Informational | Moderate | Calidi Biotherapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1 for a proposed public offering. The un… | Read Filing EDGAR |
| Aug. 19, 2025 | CORRESP | Neutral/Informational | Moderate | Calidi Biotherapeutics, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to have it… | Read Filing EDGAR |
| Jul. 24, 2025 | CORRESP | Neutral/Informational | Moderate | Calidi Biotherapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3. They are seeking to have it declared … | Read Filing EDGAR |
| Jul. 22, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Calidi Biotherapeutics, Inc. that it will not review their registration statement filed on July 18, 2025. The letter emphasizes that the responsibility… | Read Filing EDGAR |
| Jul. 10, 2025 | CORRESP | Neutral/Informational | Moderate | Calidi Biotherapeutics, Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1. They are seeking to have it declared … | Read Filing EDGAR |
| Jul. 8, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Calidi Biotherapeutics, Inc. that it will not review their registration statement filed on July 3, 2025. The letter emphasizes the company's responsibi… | Read Filing EDGAR |
| Jul. 8, 2025 | UPLOAD | Neutral/Informational | Low | The SEC correspondence dated July 8, 2025, informs Eric Poma, CEO of Calidi Biotherapeutics, Inc., that the agency does not intend to review the company's draft registration state… | Read Filing EDGAR |